Relationships between Physical Activity and Regional Phase Angle in Super-Early Postoperative Hip Fracture Patients
Rigakuryoho Kagaku · 2026 · 41 (4) · 78-82
DOI: 10.1589/rika.41.78 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rigakuryoho Kagaku, 2026. Verfasst von Takahiro TORIYAMA und 4 weiteren Autor:innen. Die Arbeit nennt 16 Literaturangaben.
Abstract (Originalsprache)
[Purpose] This study aimed to clarify the association between physical activity and regional phase angles in elderly female patients with hip fracture in the super-early postoperative period. [Participants and Methods] The study included 55 patients aged 75 years or older with hip fracture. The association between physical activity and regional phase angles was assessed using Spearman’s rank correlation coefficient. [Results] A significant correlation was found between light-intensity physical activity, sedentary time, and upper limb phase angle. [Conclusion] The results suggest the clinical usefulness of light-intensity physical activity, sedentary time, and upper limb phase angle in the super-early postoperative period of patients with hip fracture.
Zitieren
APA
TORIYAMA, T., KITAMURA, T., TAKEDA, M., IIJIMA, S., & ISHIZAKA, M. (2026). Relationships between Physical Activity and Regional Phase Angle in Super-Early Postoperative Hip Fracture Patients. Rigakuryoho Kagaku, 41(4), 78-82. https://doi.org/10.1589/rika.41.78
Vancouver
TORIYAMA T, KITAMURA T, TAKEDA M, IIJIMA S, ISHIZAKA M. Relationships between Physical Activity and Regional Phase Angle in Super-Early Postoperative Hip Fracture Patients. Rigakuryoho Kagaku. 2026;41(4):78-82. doi:10.1589/rika.41.78
BibTeX
@article{TORIYAMA2026,
author = {TORIYAMA, Takahiro and KITAMURA, Tomonori and TAKEDA, Masato and IIJIMA, Shinno and ISHIZAKA, Masahiro},
title = {Relationships between Physical Activity and Regional Phase Angle in Super-Early Postoperative Hip Fracture Patients},
journal = {Rigakuryoho Kagaku},
year = {2026},
volume = {41},
number = {4},
pages = {78--82},
doi = {10.1589/rika.41.78}
}
EUVIMED